News & Updates

Show Multimedia Only

$5-fraction SBRT improves outcomes in osseous renal cell carcinoma metastases$

5-fraction SBRT improves outcomes in osseous renal cell carcinoma metastases

21 Dec 2022

Local-control outcomes are encouraging in patients with osseous renal cell carcinoma metastases who went through five fractions of stereotactic body radiotherapy (SBRT), reports a study.

21 Dec 2022

Female, male infertility: Adherence to anti-inflammatory diets may bring new babies

21 Dec 2022 by

Anti-inflammatory dietary patterns, such as the Mediterranean diet, may improve the chances of conception among couples who struggle with infertility, according to a recent review.

21 Dec 2022

Obesity associated with adverse ITP outcomes

21 Dec 2022 by

In a study presented at ASH 2022, obesity was found to be associated with adverse outcomes in individuals with primary immune thrombocytopenia (ITP; formerly known as thrombocytopenia purpura).

21 Dec 2022

More evidence supports osimertinib for EGFR-mutated NSCLC

21 Dec 2022 by

Safety data from the phase III ADAURA study support osimertinib as an effective adjuvant therapy for resectable, stage IB–IIIA EGFR-mutated non–small-cell lung cancer (NSCLC), says an expert.

21 Dec 2022

Maternal hypothyroidism linked to adverse pregnancy outcomes

20 Dec 2022

Pregnant women with high levels of thyroid stimulating hormone (TSH), which indicate hypothyroidism, are at risk of adverse pregnancy outcomes, a study has found.

20 Dec 2022

Obesity, overweight up risk of complications from radical cystectomy

20 Dec 2022

Body mass index is independently associated with the development of complications from radical cystectomy, reports a study. Compared to patients with normal BMI, those who are overweight and obese have a higher risk.

20 Dec 2022

EMERALD updates highlight therapeutic potential of elacestrant for ER+/HER2– mBC

20 Dec 2022 by

In the updated analysis of the phase III EMERALD trial, the next-generation oral SERD* elacestrant continued to show favourable signals for the treatment of ER+/HER2– metastatic breast cancer (mBC).

20 Dec 2022

Inclisiran for lowering LDL-C yields real-world results

20 Dec 2022

Treatment with inclisiran in real-world settings appears to produce significant reductions in low-density lipoprotein cholesterol (LDL-C) at 2 months with good tolerability, with results consistent with that reported in previous trials, according to a study.

20 Dec 2022

Morning physical activity may reduce CVD risk in adults

20 Dec 2022 by

Performing physical activity in the morning, between 8:00 and 11:00 am, appears to be associated with a lower risk of cardiovascular disease (CVD), particularly coronary artery disease (CAD) and stroke, in adults than engaging in physical activity at other times of the day, a recent study has shown.

20 Dec 2022

Metformin may reduce COVID-19 severity in prediabetes, PCOS

19 Dec 2022

Among patients with prediabetes or polycystic ovary syndrome (PCOS), the use of metformin appears to be associated with lower incidence of severe COVID-19, according to a study.

19 Dec 2022

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

5-fraction SBRT improves outcomes in osseous renal cell carcinoma metastases

Female, male infertility: Adherence to anti-inflammatory diets may bring new babies

Obesity associated with adverse ITP outcomes

More evidence supports osimertinib for EGFR-mutated NSCLC

Maternal hypothyroidism linked to adverse pregnancy outcomes

Obesity, overweight up risk of complications from radical cystectomy

EMERALD updates highlight therapeutic potential of elacestrant for ER+/HER2– mBC

Inclisiran for lowering LDL-C yields real-world results

Morning physical activity may reduce CVD risk in adults

Metformin may reduce COVID-19 severity in prediabetes, PCOS